Literature DB >> 22362916

Stromal cell-derived factor-1 overexpression induces gastric dysplasia through expansion of stromal myofibroblasts and epithelial progenitors.

Wataru Shibata1, Hiroshi Ariyama, Christoph Benedikt Westphalen, Daniel L Worthley, Sureshkumar Muthupalani, Samuel Asfaha, Zinaida Dubeykovskaya, Michael Quante, James G Fox, Timothy C Wang.   

Abstract

OBJECTIVE: Stromal cell-derived factor-1 (SDF-1/CXCL12), the main ligand for CXCR4, is overexpressed in human cancer. This study addressed the precise contribution of SDF-1 to gastric carcinogenesis.
DESIGN: SDF-1 transgenic mice were created and a Helicobacter-induced gastric cancer model was used in combination with H/K-ATPase-IL-1β mice. Gastric tissue was analysed by histopathology and cells isolated from the stomach were analysed by molecular biological methods.
RESULTS: Analysis of the H/K-ATPase/SDF-1 transgenic (SDF-Tg) mice showed that SDF-1 overexpression results in significant gastric epithelial hyperproliferation, mucous neck cell hyperplasia and spontaneous gastric dysplasia (wild-type mice 0/15 (0%) vs SDF-Tg mice 4/14 (28.6%), p=0.042, Fisher exact test) but has minimal effects on inflammation. SDF-Tg mice also showed a dramatic expansion of α-smooth muscle actin-positive myofibroblasts and CXCR4-expressing gastric epithelial cells in the progenitor zone, both of which preceded the development of significant gastritis or dysplasia. Gremlin 1-expressing mesenchymal stem cells, the putative precursors of myofibroblasts, were also increased within the dysplastic stomachs of SDF-Tg mice and showed chemotaxis in response to SDF-1 stimulation. SDF-1 overexpression alone resulted in minimal recruitment of haematopoietic cells to the gastric mucosa, although macrophages were increased late in the disease. When SDF-Tg mice were crossed with H/K-ATPase-IL-1β mice or infected with Helicobacter felis, however, there were dramatic synergistic effects on recruitment of bone marrow-derived cells and progression to preneoplasia.
CONCLUSION: Activation of the SDF-1/CXCR4 axis can contribute to early stages of carcinogenesis primarily through recruitment of stromal cells and modulation of the progenitor niche.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362916      PMCID: PMC4136650          DOI: 10.1136/gutjnl-2011-301824

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  43 in total

1.  CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.

Authors:  Kyle J Eash; Jacquelyn M Means; Douglas W White; Daniel C Link
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

2.  Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro.

Authors:  Nick Barker; Meritxell Huch; Pekka Kujala; Marc van de Wetering; Hugo J Snippert; Johan H van Es; Toshiro Sato; Daniel E Stange; Harry Begthel; Maaike van den Born; Esther Danenberg; Stieneke van den Brink; Jeroen Korving; Arie Abo; Peter J Peters; Nick Wright; Richard Poulsom; Hans Clevers
Journal:  Cell Stem Cell       Date:  2010-01-08       Impact factor: 24.633

3.  SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia.

Authors:  Dah-Yuu Lu; Chih-Hsin Tang; Wei-Lan Yeh; Kar-Lok Wong; Chih-Peng Lin; Yi-Hung Chen; Chih-Ho Lai; Yuh-Fung Chen; Yuk-Man Leung; Wen-Mei Fu
Journal:  Eur J Pharmacol       Date:  2009-03-11       Impact factor: 4.432

4.  Exogenous stromal cell-derived factor-1 induces modest leukocyte recruitment in vivo.

Authors:  Steven M Kerfoot; Graciela Andonegui; Claudine S Bonder; Lixin Liu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

5.  Helicobacter-based mouse models of digestive system carcinogenesis.

Authors:  Arlin B Rogers; JeanMarie Houghton
Journal:  Methods Mol Biol       Date:  2009

6.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.

Authors:  Pravin J Mishra; Prasun J Mishra; Rita Humeniuk; Daniel J Medina; Gabriela Alexe; Jill P Mesirov; Sridhar Ganesan; John W Glod; Debabrata Banerjee
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

7.  Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines.

Authors:  Zinaida Dubeykovskaya; Alexander Dubeykovskiy; Joel Solal-Cohen; Timothy C Wang
Journal:  J Biol Chem       Date:  2008-12-08       Impact factor: 5.157

Review 8.  The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

Authors:  Erik De Clercq
Journal:  Biochem Pharmacol       Date:  2008-12-31       Impact factor: 5.858

9.  Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis.

Authors:  Satoshi Iwasa; Toru Yanagawa; Jianglin Fan; Ryohei Katoh
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

10.  Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.

Authors:  Erika L Spaeth; Jennifer L Dembinski; A Kate Sasser; Keri Watson; Ann Klopp; Brett Hall; Michael Andreeff; Frank Marini
Journal:  PLoS One       Date:  2009-04-07       Impact factor: 3.240

View more
  37 in total

1.  Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.

Authors:  Iratxe Zuazo-Gaztelu; Marta Pàez-Ribes; Patricia Carrasco; Laura Martín; Adriana Soler; Mar Martínez-Lozano; Roser Pons; Judith Llena; Luis Palomero; Mariona Graupera; Oriol Casanovas
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

Review 2.  Interaction between gastric cancer stem cells and the tumor microenvironment.

Authors:  Takatsugu Ishimoto; Hiroshi Sawayama; Hidetaka Sugihara; Hideo Baba
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

3.  Gastritis promotes an activated bone marrow-derived mesenchymal stem cell with a phenotype reminiscent of a cancer-promoting cell.

Authors:  Jessica M Donnelly; Amy C Engevik; Melinda Engevik; Michael A Schumacher; Chang Xiao; Li Yang; Roger T Worrell; Yana Zavros
Journal:  Dig Dis Sci       Date:  2013-11-08       Impact factor: 3.199

Review 4.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 5.  Bone marrow cells as precursors of the tumor stroma.

Authors:  Daniel L Worthley; Yiling Si; Michael Quante; Michael Churchill; Siddhartha Mukherjee; Timothy C Wang
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

Review 6.  Gastric cancer stem cells: a novel therapeutic target.

Authors:  Shree Ram Singh
Journal:  Cancer Lett       Date:  2013-04-10       Impact factor: 8.679

Review 7.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

8.  Obesity accelerates Helicobacter felis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response.

Authors:  Russell E Ericksen; Shannon Rose; Christoph Benedikt Westphalen; Wataru Shibata; Sureshkumar Muthupalani; Yagnesh Tailor; Richard A Friedman; Weiping Han; James G Fox; Anthony W Ferrante; Timothy C Wang
Journal:  Gut       Date:  2013-05-31       Impact factor: 23.059

Review 9.  Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?

Authors:  Yoku Hayakawa; Nilay Sethi; Antonia R Sepulveda; Adam J Bass; Timothy C Wang
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

Review 10.  Cancer stem cells: the 'heartbeat' of gastric cancer.

Authors:  Guihua Xu; Jie Shen; Xiaohui Ou Yang; Masakiyo Sasahara; Xiulan Su
Journal:  J Gastroenterol       Date:  2012-11-27       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.